GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology
GE HealthCare Announces Changes in Strategic Leadership and Key Segments to Better Serve Patients and Customers
GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World
GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five...
GE HealthCare to Hold an Investor Day in New York City on November 21, 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR systems. Neuroscience, particularly in the study of psychiatric diseases and neurological disorders such as Alzheimer’s, has been constrained by technological and biological limitations, leaving many aspects of the brain structure and functionality largely unexplored.
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
GE HealthCare, the world's leading medtech company, is looking to manufacture more products from its global portfolio in India as part of its supply chain diversification strategy. In an interview with Viswanath Pilla, Elie Chaillot, president & CEO of GE HealthCare International, called on India to simplify tax structure, give adequate reimbursement schemes and easy financing to spur expansion of the Indian healthcare market and attract more investments. Edited excerpts:
GE HealthCare and Hartford HealthCare Renew and Evolve 7-Year Collaboration
GE HealthCare Establishes the GE HealthCare Foundation